GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Asset Turnover

Tci Gene (ROCO:6879) Asset Turnover : 0.16 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Tci Gene's Revenue for the six months ended in Dec. 2023 was NT$184.0 Mil. Tci Gene's Total Assets for the quarter that ended in Dec. 2023 was NT$1,184.4 Mil. Therefore, Tci Gene's Asset Turnover for the quarter that ended in Dec. 2023 was 0.16.

Asset Turnover is linked to ROE % through Du Pont Formula. Tci Gene's annualized ROE % for the quarter that ended in Dec. 2023 was 0.78%. It is also linked to ROA % through Du Pont Formula. Tci Gene's annualized ROA % for the quarter that ended in Dec. 2023 was 0.64%.


Tci Gene Asset Turnover Historical Data

The historical data trend for Tci Gene's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Asset Turnover Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
0.78 0.69 0.99 0.49 0.29

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Asset Turnover Get a 7-Day Free Trial Premium Member Only 0.65 0.28 0.15 0.13 0.16

Competitive Comparison of Tci Gene's Asset Turnover

For the Biotechnology subindustry, Tci Gene's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tci Gene's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Tci Gene's Asset Turnover falls into.



Tci Gene Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Tci Gene's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=333.855/( (1163.329+1165.94)/ 2 )
=333.855/1164.6345
=0.29

Tci Gene's Asset Turnover for the quarter that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=183.992/( (1202.864+1165.94)/ 2 )
=183.992/1184.402
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Tci Gene  (ROCO:6879) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Tci Gene's annulized ROE % for the quarter that ended in Dec. 2023 is

ROE %**(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=7.586/974.394
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(7.586 / 367.984)*(367.984 / 1184.402)*(1184.402/ 974.394)
=Net Margin %*Asset Turnover*Equity Multiplier
=2.06 %*0.3107*1.2155
=ROA %*Equity Multiplier
=0.64 %*1.2155
=0.78 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Tci Gene's annulized ROA % for the quarter that ended in Dec. 2023 is

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=7.586/1184.402
=(Net Income / Revenue)*(Revenue / Total Assets)
=(7.586 / 367.984)*(367.984 / 1184.402)
=Net Margin %*Asset Turnover
=2.06 %*0.3107
=0.64 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Tci Gene Asset Turnover Related Terms

Thank you for viewing the detailed overview of Tci Gene's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Tci Gene (ROCO:6879) Business Description

Traded in Other Exchanges
N/A
Address
No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines